VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Brain Cancer
Related studies linked through entity extraction aliases.
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery
- Status
- COMPLETED
- Phase
- NA
Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression
- Status
- COMPLETED
- Phase
- PHASE2
Refining and Testing the Electronic Social Network Assessment Program (eSNAP)
- Status
- COMPLETED
- Phase
- N/A
Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Radiotherapy for Metastases of Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
- Status
- COMPLETED
- Phase
- N/A
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
- Status
- COMPLETED
- Phase
- N/A
Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas
- Status
- COMPLETED
- Phase
- NA
Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)
- Status
- COMPLETED
- Phase
- PHASE1
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- Status
- RECRUITING
- Phase
- PHASE2
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
- Status
- COMPLETED
- Phase
- PHASE2
Cambridge Brain Mets Trial 1
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Early Life Exposures in Agriculture
- Status
- COMPLETED
- Phase
- N/A
Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
- Status
- COMPLETED
- Phase
- PHASE2
Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants
- Status
- COMPLETED
- Phase
- PHASE4
Biomarker Analysis of Central Nervous System Tumors
- Status
- TERMINATED
- Phase
- N/A
Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2